Skip to content

The Cochrane database of systematic reviews

ISSN 1469-493X

6 papers in the library · 20 citations · publishing 2006-2026

Papers

Sort Most recent Most cited

Cannabis-based medicines for chronic neuropathic pain in adults.

The Cochrane database of systematic reviews January 19, 2026 Gülay Ateş, Patrick Welsch, Petra Klose et al. 5 citations

Estimates of the population prevalence of chronic pain with neuropathic components range from 6% to 10%. Current pharmacological treatments for neuropathic pain help only a minority. New treatments are needed. Cannabis is increasingly promoted in the media as a treatment for chronic pain. This is an update of a review first published in 2018. To assess the benefits and harms of cannabis-based...

Meditation for the primary and secondary prevention of cardiovascular disease.

The Cochrane database of systematic reviews February 15, 2024 Karen Rees, Andrea Takeda, Rachel Court et al. 15 citations

Interventions incorporating meditation to address stress, anxiety, and depression, and improve self-management, are becoming popular for many health conditions. Stress is a risk factor for cardiovascular disease (CVD) and clusters with other modifiable behavioural risk factors, such as smoking. Meditation may therefore be a useful CVD prevention strategy. To determine the effectiveness of...

WITHDRAWN: Transcendental meditation for the primary prevention of cardiovascular disease.

The Cochrane database of systematic reviews November 15, 2017 Louise Hartley, Angelique Mavrodaris, Nadine Flowers et al.

A major determinant in cardiovascular disease (CVD) is stress. As transcendental meditation (TM) is thought to help in lowering negative stress indicators, it may be a beneficial strategy for the primary prevention of CVD. To determine the effectiveness of TM for the primary prevention of CVD. We searched the following electronic databases: the Cochrane Central Register of Controlled Trials...

Meditation therapies for attention-deficit/hyperactivity disorder (ADHD).

The Cochrane database of systematic reviews June 16, 2010 Thawatchai Krisanaprakornkit, Chetta Ngamjarus, Chartree Witoonchart et al.

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common developmental disorders experienced in childhood and can persist into adulthood. The disorder has early onset and is characterized by a combination of overactive, poorly modulated behavior with marked inattention. In the long term it can impair academic performance, vocational success and social-emotional development....

Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.

The Cochrane database of systematic reviews April 18, 2007 M A Gillman, F J Lichtigfeld, T N Young

Alcoholism is a global problem with 5-10% of the world's population demonstrating alcohol-related diseases. One of the most severe consequences of alcohol dependence is the withdrawal syndrome, for which benzodiazepines are the most popular current treatment. An alternative method to benzodiazepine employs psychotropic analgesic nitrous oxide (PAN). To assess the effects of PAN for treating...

Meditation therapy for anxiety disorders.

The Cochrane database of systematic reviews January 25, 2006 T Krisanaprakornkit, W Krisanaprakornkit, N Piyavhatkul et al.

Anxiety disorders are characterised by long term worry, tension, nervousness, fidgeting and symptoms of autonomic system hyperactivity. Meditation is an age-old self regulatory strategy which is gaining more interest in mental health and psychiatry. Meditation can reduce arousal state and may ameliorate anxiety symptoms in various anxiety conditions. To investigate the effectiveness of...